New cyclosporine drop improves signs of dry eye
- Posted on: Nov 19 2019
- Leave a response
This phase 3 trial assessed the safety and efficacy of OTX-101, an aqueous nanomicellar formulation of cyclosporine 0.09% for dry eye disease.
Source: AAO
Posted in: Uncategorized
